Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-17T02:36:37.622Z Has data issue: false hasContentIssue false

Haloperidol: a Controlled Trial in Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

J. W. Garry
Affiliation:
Suffolk Mental Hospitals
T. J. Leonard
Affiliation:
St. Audry's Hospital, Melton, Woodbridge
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Haloperidol is a comparatively new tranquillizing drug synthesized by Janssen et al. (1959). It is chemically unrelated to other drugs acting on the nervous system. It is a substituted butyrophenone whose formula is 4-fluro-4(1-[4-hydroxy-4-(4-chloro)-phenyl-piperidino]) butyrophenone.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1962 
Submit a response

eLetters

No eLetters have been published for this article.